Michelle Lock
Director Ejecutivo en RELIEF THERAPEUTICS HOLDING SA .
Cargos activos de Michelle Lock
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Director/Miembro de la Junta | 28/01/2022 | - |
| Director Ejecutivo | 01/11/2023 | - |
Historial de carrera de Michelle Lock
Antiguos cargos conocidos de Michelle Lock.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Director de Operaciones | 07/02/2022 | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Suiza | 2 |
| Estados Unidos | 2 |
| Países Bajos | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Empresas privadas | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Lock
- Experiencia